Experience

DualityBio Announces HK$1.64 Billion IPO

April 24, 2025

Cooley advised the underwriters of Duality Biologics (DualityBio), a clinical-stage biotech company focused on the discovery and development of next-generation antibody-drug conjugate therapeutics for patients with cancer and autoimmune diseases, in connection with its HK$1.64 billion global initial public offering (IPO).

Read more

Related contacts

Yiming Liu
Partner in Charge – Shanghai, Shanghai
Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Xander Lee
Partner, Santa Monica
Vince Sampson
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Monica Xu
Special Counsel, Shanghai
Hilda Li
Associate, Hong Kong
Zixiang Liu
Associate, Shanghai
Patrick Sharma
Associate, Santa Monica
Yiying Wang
Associate, Shanghai
Yunxiang Xu
Associate, Shanghai
Kaiting Yang
Associate, Hong Kong
Tonny Yu
Associate, Hong Kong
Tonny Yu
Associate, Hong Kong
Letian Wei
Legal Consultant, Shanghai
Cindy Pan
International Legal Project Manager, Hong Kong
Zoe Wang
International Legal Project Manager, Shanghai
Philip Kwan
Senior Legal Assistant, Hong Kong
Jin Wang
Senior Legal Assistant, Beijing

Related Practices & Industries

ProfoundBio Announces $112 Million Oversubscribed Series B

February 14, 2024

Cooley advised ProfoundBio, a clinical-stage biotechnology company developing novel antibody-drug conjugate therapeutics for patients with cancer, on its $112 million oversubscribed Series B financing.

Read more

Related contacts

Patrick Loofbourrow
Partner, Singapore
Monica Xu
Special Counsel, Shanghai
Ivy Wang
Associate, Shanghai
Zixiang Liu
Associate, Shanghai
Xander Lee
Partner, Santa Monica
Charlie Kim
Partner, San Diego
Christopher Kimball
Partner, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Sarah Oliai
Associate, Washington, DC
Letian Wei
Legal Consultant, Shanghai

Related Practices & Industries

SJ Semiconductor Signs $340 Million Series C+ Financing

April 12, 2023

Cooley advised SJ Semiconductor Corporation (SJSemi), a semiconductor foundry, on its $340 million Series C+ financing, with a post-money valuation of close to US$2 billion.

Related contacts

Ruomu Li
Partner, Shanghai
Wenlan Geng
Associate, Shanghai
Zixiang Liu
Associate, Shanghai

Related Practices & Industries

Admissions and credentials

California

New York